KNIGHT THERAPEUTICS INCKNIGHT THERAPEUTICS INCKNIGHT THERAPEUTICS INC

KNIGHT THERAPEUTICS INC

No trades
See on Supercharts
Market capitalization
‪578.69 M‬CAD
−0.17CAD
‪−16.84 M‬CAD
‪328.20 M‬CAD
‪64.96 M‬
Beta (1Y)
0.12

About KNIGHT THERAPEUTICS INC

CEO
Samira Sakhia
Headquarters
Montréal
Employees (FY)
725
Founded
2013
FIGI
BBG006373G71
Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals products. The firm also focuses on building a portfolio of innovative products through in-licensing or acquiring product rights. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montréal, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of GUD is 5.79 CAD — it has increased by 1.22% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSX exchange KNIGHT THERAPEUTICS INC stocks are traded under the ticker GUD.
KNIGHT THERAPEUTICS INC is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
GUD stock is 1.40% volatile and has beta coefficient of 0.12. Check out the list of the most volatile stocks — is KNIGHT THERAPEUTICS INC there?
One year price forecast for KNIGHT THERAPEUTICS INC has a max estimate of 7.60 CAD and a min estimate of 5.25 CAD.
GUD earnings for the last quarter are 0.09 CAD per share, whereas the estimation was −0.03 CAD resulting in a 377.16% surprise. The estimated earnings for the next quarter are −0.01 CAD per share. See more details about KNIGHT THERAPEUTICS INC earnings.
KNIGHT THERAPEUTICS INC revenue for the last quarter amounts to ‪81.50 M‬ CAD despite the estimated figure of ‪73.46 M‬ CAD. In the next quarter revenue is expected to reach ‪78.70 M‬ CAD.
Yes, you can track KNIGHT THERAPEUTICS INC financials in yearly and quarterly reports right on TradingView.
GUD stock has fallen by 1.53% compared to the previous week, the month change is a 10.29% rise, over the last year KNIGHT THERAPEUTICS INC has showed a 20.12% increase.
GUD net income for the last quarter is ‪−24.33 M‬ CAD, while the quarter before that showed ‪9.59 M‬ CAD of net income which accounts for −353.71% change. Track more KNIGHT THERAPEUTICS INC financial stats to get the full picture.
Today KNIGHT THERAPEUTICS INC has the market capitalization of ‪585.77 M‬, it has increased by 9.40% over the last week.
No, GUD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, GUD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KNIGHT THERAPEUTICS INC stock right from TradingView charts — choose your broker and connect to your account.
GUD reached its all-time high on Dec 5, 2016 with the price of 11.03 CAD, and its all-time low was 3.51 CAD and was reached on Mar 3, 2014.
See other stocks reaching their highest and lowest prices.
As of Apr 23, 2024, the company has 725.00 employees. See our rating of the largest employees — is KNIGHT THERAPEUTICS INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So KNIGHT THERAPEUTICS INC technincal analysis shows the buy rating today, and its 1 week rating is strong buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating KNIGHT THERAPEUTICS INC stock shows the buy signal. See more of KNIGHT THERAPEUTICS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on KNIGHT THERAPEUTICS INC future price: according to them, GUD price has a max estimate of 7.60 CAD and a min estimate of 5.25 CAD. Read a more detailed KNIGHT THERAPEUTICS INC forecast: see what analysts think of KNIGHT THERAPEUTICS INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KNIGHT THERAPEUTICS INC EBITDA is ‪56.82 M‬ CAD, and current EBITDA margin is 17.31%. See more stats in KNIGHT THERAPEUTICS INC financial statements.